NO983777L - 3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater - Google Patents

3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater

Info

Publication number: NO983777L
Authority: NO; Norway
Prior art keywords: carbon atom; amino; disubstituted; configuration; tetralinecarboxamide
Prior art date: 1996-02-19

Application number

NO983777A

Other languages

English (en)

Other versions

NO323095B1 (no

NO983777D0 (no

Inventor

Makio Kitazawa

Kosuke Okazaki

Tetsuro Tamai

Masaru Saito

Nobuyuki Tanaka

Hiroaki Kobayashi

Ken Kikuchi

Hideyuki Muranaka

Original Assignee

Kissei Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-19

Filing date

1998-08-18

Publication date

1998-10-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13386565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983777(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-18 Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical

1998-08-18 Publication of NO983777D0 publication Critical patent/NO983777D0/no

1998-10-19 Publication of NO983777L publication Critical patent/NO983777L/no

2007-01-02 Publication of NO323095B1 publication Critical patent/NO323095B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Detergent Compositions (AREA)

NO19983777A 1996-02-19 1998-08-18 3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater NO323095B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP6888596		1996-02-19
PCT/JP1997/000424 WO1997030023A1 (en)	1996-02-19	1997-02-18	3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives

Publications (3)

Publication Number	Publication Date
NO983777D0 NO983777D0 (no)	1998-08-18
NO983777L true NO983777L (no)	1998-10-19
NO323095B1 NO323095B1 (no)	2007-01-02

Family

ID=13386565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19983777A NO323095B1 (no)	1996-02-19	1998-08-18	3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater

Country Status (24)

Country	Link
US (1)	US6133266A (no)
EP (1)	EP0882704B1 (no)
JP (1)	JP3892045B2 (no)
KR (1)	KR100491633B1 (no)
CN (1)	CN1100032C (no)
AT (1)	ATE225767T1 (no)
AU (1)	AU725042B2 (no)
BR (1)	BR9707566B1 (no)
CA (1)	CA2245490C (no)
CZ (1)	CZ293974B6 (no)
DE (1)	DE69716242T2 (no)
DK (1)	DK0882704T3 (no)
EA (1)	EA002143B1 (no)
ES (1)	ES2184989T3 (no)
HU (1)	HU229400B1 (no)
ID (1)	ID16091A (no)
MY (1)	MY123853A (no)
NO (1)	NO323095B1 (no)
NZ (1)	NZ331445A (no)
PL (1)	PL186411B1 (no)
PT (1)	PT882704E (no)
SG (1)	SG72727A1 (no)
TW (1)	TW375604B (no)
WO (1)	WO1997030023A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8562098A (en) *	1997-08-19	1999-03-08	Kissei Pharmaceutical Co. Ltd.	Phenylethanolaminotetralin derivatives and bronchodilators
ZA994264B (en)	1998-07-01	2000-01-25	Warner Lambert Co	Stereoisomers with high affinity for adrenergic receptors.
GB9913083D0 (en)	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
US7232837B2 (en)	1999-06-29	2007-06-19	Mcneil-Ppc, Inc.	Stereoisomers with high affinity for adrenergic receptors
FR2809725B1 (fr) *	2000-06-06	2004-05-07	Sanofi Synthelabo	Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
GB0029562D0 (en)	2000-12-04	2001-01-17	Novartis Ag	Organic compounds
AU2004206161B2 (en) *	2003-01-22	2008-07-03	Kissei Pharmaceutical Co., Ltd.	Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
JPWO2006054514A1 (ja) *	2004-11-19	2008-05-29	キッセイ薬品工業株式会社	神経因性疼痛の予防又は治療用医薬組成物
WO2006054513A1 (ja) *	2004-11-19	2006-05-26	Kissei Pharmaceutical Co., Ltd.	神経因性疼痛の予防又は治療剤
EP2098511A1 (en)	2008-03-07	2009-09-09	Solvias AG	Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
MX2012005661A (es) *	2009-11-18	2012-09-07	Medicinova Inc	Tratamiento de exacerbacion aguda de asma y reduccion de probabilidad de hospitalizacion de pacientes que sufren de la misma.
US20120035265A1 (en) *	2010-03-08	2012-02-09	Medicinova, Inc.	Compositions, methods, and devices for the treatment of dysmenorrhea
CA2794849A1 (en) *	2010-04-08	2011-10-13	Medicinova, Inc.	Methods and compositions for the treatment of irritable bowel syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9107827D0 (en) *	1991-04-12	1991-05-29	Fujisawa Pharmaceutical Co	New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) *	1992-02-03	1997-03-18	Fujisawa Pharmaceutical Co	Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1993018007A1 (fr) *	1992-03-13	1993-09-16	Tokyo Tanabe Company Limited	Nouveau derive de carbostyrile

1997
- 1997-02-17 TW TW086102182A patent/TW375604B/zh not_active IP Right Cessation
- 1997-02-17 SG SG1997000355A patent/SG72727A1/en unknown
- 1997-02-18 DE DE69716242T patent/DE69716242T2/de not_active Expired - Lifetime
- 1997-02-18 ES ES97902714T patent/ES2184989T3/es not_active Expired - Lifetime
- 1997-02-18 CZ CZ19982523A patent/CZ293974B6/cs not_active IP Right Cessation
- 1997-02-18 US US09/125,429 patent/US6133266A/en not_active Expired - Lifetime
- 1997-02-18 WO PCT/JP1997/000424 patent/WO1997030023A1/ja not_active Ceased
- 1997-02-18 CA CA002245490A patent/CA2245490C/en not_active Expired - Lifetime
- 1997-02-18 AT AT97902714T patent/ATE225767T1/de active
- 1997-02-18 JP JP52920097A patent/JP3892045B2/ja not_active Expired - Lifetime
- 1997-02-18 PL PL97328530A patent/PL186411B1/pl unknown
- 1997-02-18 MY MYPI97000600A patent/MY123853A/en unknown
- 1997-02-18 CN CN97193866A patent/CN1100032C/zh not_active Expired - Lifetime
- 1997-02-18 BR BRPI9707566-3A patent/BR9707566B1/pt not_active IP Right Cessation
- 1997-02-18 HU HU9900621A patent/HU229400B1/hu unknown
- 1997-02-18 EA EA199800644A patent/EA002143B1/ru not_active IP Right Cessation
- 1997-02-18 NZ NZ331445A patent/NZ331445A/xx not_active IP Right Cessation
- 1997-02-18 KR KR10-1998-0706378A patent/KR100491633B1/ko not_active Expired - Lifetime
- 1997-02-18 PT PT97902714T patent/PT882704E/pt unknown
- 1997-02-18 DK DK97902714T patent/DK0882704T3/da active
- 1997-02-18 AU AU20014/97A patent/AU725042B2/en not_active Expired
- 1997-02-18 EP EP97902714A patent/EP0882704B1/en not_active Expired - Lifetime
- 1997-02-19 ID IDP970478A patent/ID16091A/id unknown
1998
- 1998-08-18 NO NO19983777A patent/NO323095B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1100032C (zh)	2003-01-29
WO1997030023A1 (en)	1997-08-21
PL186411B1 (pl)	2004-01-30
HUP9900621A3 (en)	1999-11-29
DE69716242T2 (de)	2003-07-24
JP3892045B2 (ja)	2007-03-14
DE69716242D1 (de)	2002-11-14
BR9707566A (pt)	1999-07-27
HUP9900621A2 (hu)	1999-08-30
MY123853A (en)	2006-06-30
SG72727A1 (en)	2000-05-23
EP0882704A1 (en)	1998-12-09
TW375604B (en)	1999-12-01
ES2184989T3 (es)	2003-04-16
NZ331445A (en)	2000-01-28
CA2245490C (en)	2005-10-25
CA2245490A1 (en)	1997-08-21
CN1216526A (zh)	1999-05-12
US6133266A (en)	2000-10-17
PT882704E (pt)	2003-02-28
KR19990082638A (ko)	1999-11-25
NO323095B1 (no)	2007-01-02
ID16091A (id)	1997-09-04
AU2001497A (en)	1997-09-02
BR9707566B1 (pt)	2010-08-10
EA002143B1 (ru)	2001-12-24
CZ293974B6 (cs)	2004-09-15
KR100491633B1 (ko)	2005-09-09
DK0882704T3 (da)	2003-02-17
ATE225767T1 (de)	2002-10-15
CZ252398A3 (cs)	1998-12-16
EP0882704A4 (en)	2000-06-14
EA199800644A1 (ru)	1999-02-25
AU725042B2 (en)	2000-10-05
EP0882704B1 (en)	2002-10-09
NO983777D0 (no)	1998-08-18
PL328530A1 (en)	1999-02-01
HU229400B1 (en)	2013-12-30

Publication	Publication Date	Title
NO983777D0 (no)	1998-08-18	3,4-Disubstituerte fenyletanolamintetralinkarboksamidderivater
ES2141137T3 (es)	2000-03-16	Agentes terapeuticos para la enfermedad de parkinson.
PT93066A (pt)	1990-08-31	Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem
ES2051834T3 (es)	1994-07-01	El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
DE69713319D1 (de)	2002-07-18	3,4-disubstituierte phenylethanolaminotetralincarboxylat-derivate
NO913023L (no)	1991-08-02	Nye bicykliske aminosubstituerte forbindelser
ES2109216T3 (es)	1998-01-16	Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
NO984699D0 (no)	1998-10-08	Fenyletanolamino-tetralinkarboks-amid-derivater
KR920008034A (ko)	1992-05-27	항고혈압 작용 및 혈관 확장 활성있는 벤조피란 유도체, 그의 제법 및 그의 치료적 용도
EP0919233B8 (en)	2003-08-13	Therapeutic agent for kidney diseases
EP0420464A3 (en)	1991-07-17	3-isoxazolone derivatives, their preparation and their therapeutic uses

Legal Events

Date	Code	Title	Description
2017-03-06	MK1K	Patent expired